Mary Jo Dales

News

In myelodysplastic syndrome, improved tool for predicting death after HCT

Author:: Mary Jo Dales

Publish date: April 11, 2016

Key clinical point: A portion of patients with myelodysplastic syndrome in high- and very high–risk groups of the revised International Prog...

News

OTX015 dose for lymphoma narrowed in phase 1 study

Author:: Mary Jo Dales

Publish date: April 10, 2016

Key clinical point: For lymphoma patients, a regimen has been determined for the small-molecule inhibitor OTX015 that was associated with acceptab...

News

LMWH doesn’t reduce late pregnancy loss in women with thrombophilias

Author:: Mary Jo Dales

Publish date: April 6, 2016

Prophylactic-dose low molecular weight heparin, with or without aspirin, did not reduce the risk of pregnancy loss in women with inherited thrombophil...

News

CHEST issues guidelines on EBUS-TBNA

Author:: Mary Jo Dales

Publish date: March 31, 2016

News

Idelalisib use halted in six combo therapy trials, FDA announces

Author:: Mary Jo Dales

Publish date: March 15, 2016

News

Guidelines on asparaginase hypersensitivity and silent inactivation in ALL

Author:: Mary Jo Dales

Publish date: March 11, 2016

The recommendations address therapeutic drug monitoring through serum asparaginase level assessment, indications for switching asparaginase preparatio...

News

HIV drug may overcome proteasome-inhibitor resistance in multiple myeloma

Author:: Mary Jo Dales

Publish date: March 11, 2016

Key clinical point: Adding HIV protease inhibitors to established combinations of proteasome inhibitors may improve outcomes in patients with mult...

News

Follicular lymphoma: Quantitative PET/CT measures for detecting bone marrow involvement

Author:: Mary Jo Dales

Publish date: March 10, 2016

Key clinical point: Measuring the mean standardized uptake value of 18fluorodeoxyglucose in the bone marrow of patients with follicular lymphoma im...